Evidence map›Paper›PMID 39315505›Full record

ArticlePigment cell & melanoma research2025

Germline Variants in Patients Affected by Both Uveal and Cutaneous Melanoma.

Peter A Johansson, Jane M Palmer, Lindsay McGrath, Sunil Warrier, Hayley R Hamilton, Timothy Beckman, Matthew G D'Mellow, Kelly M Brooks, William Glasson, Nicholas K Hayward and 1 more

Abstract read
In one paragraph

Article in Pigment cell & melanoma research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. The Genetic and Molecular Analyses of Rare Candidate GermlineInternational journal of molecular sciences · 2026
    Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Peter A JohanssonQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0001-7015-5452
Jane M PalmerQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0002-2702-522X
Lindsay McGrathQueensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.ORCID 0000-0003-0925-1124
Sunil WarrierQueensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.
Hayley R HamiltonQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0001-5899-1458
Timothy BeckmanQueensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.ORCID 0000-0002-8364-9643
Matthew G D'MellowQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
Kelly M BrooksQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
William GlassonQueensland Ocular Oncology Service, The Terrace Eye Centre, Brisbane, Queensland, Australia.
Nicholas K HaywardQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0003-4760-1033
Antonia L PritchardQIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.ORCID 0000-0001-5336-0454

Funding

Buck Off MelanomaGlen LawHighlands and Islands EnterpriseNational Health and Medical Research Councilthe St Mary's Anglican Parish of Kangaroo Point
6 · The paper itself

Abstract

Uveal melanoma (UM) and nonacral cutaneous melanoma (CM) are distinct entities with varied genetic landscapes despite both arising from melanocytes. There are, however, similarities in that they most frequently affect people of European ancestry, and high penetrance germline variants in BAP1, POT1 and CDKN2A have been shown to predispose to both UM and CM. This study aims to further explore germline variants in patients affected by both UM and CM, shedding light on the underlying genetic mechanism causing these diseases. Using exome sequencing we analysed germline DNA samples from a cohort of 83 Australian patients diagnosed with both UM and CM. Eight (10%) patients were identified that carried pathogenic mutations in known melanoma predisposition genes POT1, MITF, OCA2, SLC45A2 and TYR. Three (4%) patients carried pathogenic variants in genes previously linked with other cancer syndromes (ATR, BRIP1 and MSH6) and another three cases carried monoallelic pathogenic variants in recessive cancer genes (xeroderma pigmentosum and Fanconi anaemia), indicating that reduced penetrance of phenotype in these individuals may contribute to the development of both UM and CM. These findings highlight the need for further studies characterising the role of these genes in melanoma susceptibility.

Indexed as

Genetic Predisposition to DiseaseGerm-Line MutationMelanomaSkin NeoplasmsUveal NeoplasmsAdultAgedAged, 80 and overCutaneous Malignant MelanomaFemaleHumansMaleMiddle AgedUveal Melanomacutaneous melanomagenetic riskgermline variantssequencinguveal melanoma

Identifiers

PMID39315505
PMCPMC11681841

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.